Assembly Biosciences, Inc. (ASMB) Net margin 2017–2025
Assembly Biosciences, Inc. (ASMB) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.5%FY2025 · since FY2017: -474.7% → -8.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.5% | +132.4 pp |
| FY2024 | -140.9% | +713.9 pp |
| FY2023 | -854.8% | — |
| FY2021 | -2076.4% | -1997.8 pp |
| FY2020 | -78.6% | +533.1 pp |
| FY2019 | -611.6% | +1.4 pp |
| FY2018 | -613.0% | -138.4 pp |
| FY2017 | -474.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ASMB financial trends
ASMB RevenueASMB Net incomeASMB Gross profitASMB Gross marginASMB Operating incomeASMB Operating marginASMB Operating cash flowASMB Free cash flowASMB Capital expendituresASMB Return on equityASMB Stock buybacksASMB Dividends paidASMB Total assetsASMB Total liabilitiesASMB Shareholders’ equityASMB overview →